Docebo vs VTEX
Docebo reported revenue of $243 million in fiscal 2025, about the same as VTEX's $240 million in fiscal 2025. Docebo's revenue grew 11.9% in its latest year, and VTEX's grew 6.1%. Docebo had an operating margin of 9.6%, against 7.5% at VTEX. Free cash flow was $27 million at Docebo and $32 million at VTEX.
Side by side
| Docebo | VTEX | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $243M | $240M |
| Revenue growth | 11.9% | 6.1% |
| Revenue growth a year, last 5 years | 31.0% | 19.5% |
| Gross margin | 80.3% | 77.5% |
| Operating margin | 9.6% | 7.5% |
| Net margin | 15.5% | 8.3% |
| Free cash flow | $27M | $32M |
| Free cash flow margin | 11.2% | 13.4% |
| Return on capital | — | 39.9% |
| Net debt to EBITDA | −2.8x | −9.0x |
| Dividends and buybacks | $0M | $59M |
| Change in diluted share count | −5.2% | −3.8% |
| Last close | $29.39 | $3.24 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | — | sold $2.0 million |
| Piotroski F-score | 5 of 9 | 6 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
DoceboVTEX
Operating margin
Percent of revenue
DoceboVTEX
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
DoceboVTEX